Fig. 2From: Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trialPercentage of patients reporting clinically meaningful improvements in EORTC QLQ-C30 functional and symptom scales at 36 months. Clinically meaningful improvement defined as a ≥ 10-point improvement from baseline scoreBack to article page